期刊文献+

利用T1加权动态对比度增强灌注MRI技术确定脑胶质瘤放疗靶区的研究 被引量:3

The role of T1-weighted dynamic contrast-enhanced perfusion magnetic resonance imaging in gross target volume delineation of giioma patients
原文传递
导出
摘要 目的探讨利用T1加权动态对比度增强灌注MRI(DCEPMRI)技术在放疗中确定脑胶质瘤临床靶区的研究。方法对28例脑胶质瘤患者团注顺磁性造影剂Gd—DTPA后,采集其T1加权DCEPMRI,对获得图像用改进的Torts—Kermode两室分析模型和反卷积法进行处理分析得到微血管通透性相关定量参数Ktrans值及图,并比较最大病灶区所在层面常规增强MRI与T1加权DCEPMRI的Ktrans值及图,测量各个临床级别脑胶质瘤病灶面积差异。结果低级别胶质瘤微血管通透性较低、肿瘤浸润范围小,T1加权DCEPMRI与常规增强MRI所测病灶面积误差达0.2%-0.3%[I、Ⅱ级分别为2.93cm2:2.46cm2(t=6.90,P=0.000)、4.18cm2:3.21cm2(t=10.22,P=0.000)];高级别胶质瘤微血管通透性较高、肿瘤浸润范围大,T1加权DCEPMRI与常规增强MRI所测量病灶面积误差达25.1%~26.3%[Ⅲ、Ⅳ级分别为6.46cm2:5.48cm2(t=10.83,P=0.000)、8.26cm2:6.52cm2(t=18.53,P=0.000)]。结论以T1加权DCEPMRI技术得到的微血管通透性相关定量参数Ktrans值及彩图为胶质瘤放疗靶区确定提供了更为准确信息,可作为评价肿瘤体积新方法。 Objective To investigate whether the Tl-weighted dynamic contrast-enhanced perfusion magnetic resonance imaging (DCEPMRI) technique can help to delineate the clinical target volume of brain glioma patients. Methods The DCE T1-weighted images from 28 glioma patients were collected after Gd- DTPA was injected. After the acquired images were processed and analyzed using modified Tofts-Kermode' two compartment analysis model and de-convolution method, the value and its pseudo mapping of quantitative parameter K related to microvascular permeability were obtained. The tumor size in the largest diameter slice measured both in routine enhanced MRI and Ktrans mapping of Tl-weighted DCEPMRI were compared. Results The vascular permeability and tumor infiltration was lower in low grade glioma, the difference of the tumor size between Tl-weighted DCEPMRI and routine enhanced MRI reached 0. 2% -0. 3% there was significant difference of tumor size between Tl-weighted DCEPMRI and routine enhanced MRI ( grade I and II grade with 2.93 cm2:2.46 cm2(t=6.90,P=0.000) and 4. 18 cm2:3.21 cm2(t= 10.22,P= 0. 000) ). While in high grade glioma, the vascular permeability and the tumor infiltration were higher, the difference of the tumor size between Tl-weighted DCEPMRI and routine enhanced MRI reached 25% - 26% (the size of grade HI and IV were 6. 46 cm2 vs 5.48 cm2(t = 10. 83,P =0. 000) and 8.26 cm2 vs 6. 52 cm2 (t = 18. 53, P = 0. 000)). Conclusions The pseudo mapping of quantitative parameter K related to microvascular permeability acquired by Tl-weighted DCEPMRI reflect the infiltrating circumscription in glioma, T1-weighted DCEPMRI can provide more information in delineation the clinical target volume, and it can be used as a new method for tumor volume evaluation.
出处 《中华放射肿瘤学杂志》 CSCD 北大核心 2012年第4期310-313,共4页 Chinese Journal of Radiation Oncology
关键词 动态对比度增强灌注磁共振成像 T1加权 微血管通透性 脑肿瘤/放射疗法 靶体积勾画 Dynamic contrast-enhanced perfusion magnetic resonance imaging, T1-weighted Mierovascular permeability Brain neoplasms/radiotherapy Delineation of target volume
  • 相关文献

参考文献13

  • 1Giraud P,Kantor G,Loiseau H. Target definition in the thorax and central nervous system[J].Seminars in Radiation Oncology,2005.146-156.
  • 2邓振生,张娜,孟莉,王小宜,廖伟华,HOU BL.利用T_1加权DCE-MRI技术对脑胶质瘤分级[J].中国生物医学工程学报,2010,29(1):16-21. 被引量:9
  • 3Kantor G,Loiseau H,Vital A. Gross tumor volume (GTV)and clinical target volume (CTV) in adult gliomas[J].Cancer Radiotherapy,2001.571-580.
  • 4蒋马伟,周仁华,姚原,林青,夏士安,吴国华.脑胶质瘤放疗靶区确定的方法学研究[J].中华肿瘤防治杂志,2007,14(13):997-999. 被引量:8
  • 5Cron GO,Kelcz F,Santyr GE. Improvement in breast lesion characterization with dynamic contrast-enhanced MRI using pharmacokinetic modeling and bookend T1 measurements[J].Magn Reron Med,2004.1066-1070.
  • 6Workie DW,Dardzinski BJ,Graham TB. Quantification of dynamic contrast-enhanced MR imaging of the knee in children with juvenile rheumatoid arthritis based on pharmacokinetic modeling[J].Magnetic Resonance Imaging,2004.1201-1210.
  • 7Toffs PS,Brix G,Buckley DL. Estimating kinetic parameters from dynamic contrast-enhanced T1-weighted MRI of a diffusable tracer:standardized quantities and symbols[J].Journal of Magnetic Resonance Imaging,1999.223-232.
  • 8夏爽,郭文梅,祁吉.胶质瘤的血管生成与MR灌注成像技术的相关研究[J].国外医学(临床放射学分册),2003,26(3):169-173. 被引量:3
  • 9王建利,谢敬霞.MR灌注及扩散成像在脑血液动力学与急性脑缺血病理生理研究中的应用[J].中华放射学杂志,1998,32(6):370-374. 被引量:22
  • 10Jain R,Ellika SK,Scarpace L. Quantitative estimation of permeability surface-area product in astroglial brain tumors using perfusion CT and correlation with histopathologic grade[J].American Journal of Neuroradiology,2008.694-700.

二级参考文献59

  • 1Provenzale JM, Mukundan S, Barboriak DP. Diffusion-weighted and perfusion MR imaging for brain tumor characterization and assessment of treatment response [J]. Radiology, 2006, 239: 632 - 649.
  • 2O'Connor JPB, Watson Y, Jackson A. Dynamic contrastenhanced MR imaging in cancer [ J]. Radiography, 2007, 13: e45 - e53.
  • 3de Bazelaire CMJ, Duhamel GD, Rofsky NM, et aL MR imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0 T preliminary results [ J]. Radiology, 2004, 230(3 ) : 652 - 659.
  • 4Haroon HA, Patankar TF, Zhu XP, et al. Comparison of cerebral blood volume maps generated from T2 * and T1 weighted MRI data in intra-axial cerebral tumours [J].The British Journal of Radiology, 2007, 80(951 ) : 161 - 168.
  • 5Bickel U. How to measure drug transport across the blood-brain barrier [J]. The Journal of the American Society for Experimental NeuroTherapeutics, 2005, 2:15 -26.
  • 6Provenzale JM, Mukundan S, Dewhirst M. The role of blood - brain barrier permeability in brain tumor imaging and therapeutics [ J]. AJR, 2005, 185:763 -767.
  • 7Mills SJ, Patankar TA, Haroon HA, et al. Do cerebral blood volume and contrast transfer coefficient predict prognosis in human glioma? [ J] AJNR, 2006, 27 : 853 - 858.
  • 8Cha S, Knopp EA, Johnson G, et al. Intraeranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging [J]. Radiology, 2002, 223 ( 1 ) : 11 - 29.
  • 9Orth RC, Bankson J, Price R, et al. Comparison of single-and dual-tracer pharmacokinetic modeling of dynamic contrast- enhanced MRI data using low, medium, and high molecular weight contrast agents [J]. Magnetic Resonance in Medicine, 2007, 58:705-716.
  • 10Buckley DL. Uncertainty in the analysis of tracer kinetics using dynamic contrast-enhanced Tl-weighted MRI [J], Magnetic Resonance in Medicine, 2002, 47:601 -606.

共引文献38

同被引文献26

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部